Calcium folinate pentahydrate
Recurrent Pancreatic Carcinoma
Oncolytics BiotechSmall moleculePhase 2Active
BBB
78/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 67/ 100
- Competitive Position
- 95/ 100
Competitive context
8 Active assets in the Recurrent Pancreatic Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Eloxatin OHSU Knight Cancer Institute | Phase 2/3 | BBB |
FLUOROURACILUM Northwestern University | Phase 2/3 | BBB |
Irinotecan OHSU Knight Cancer Institute | Phase 2/3 | BBB |
Gdc-0449 OHSU Knight Cancer Institute | Phase 2 | BB |
Cediranib University of Nebraska | Phase 2 | B |
View all 24 →
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →